Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

The president used to trash exercise and wellness culture. Now he’s rebooting the outdated Presidential Fitness Test as a ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...

Medicare Advantage, the privately run insurance on which roughly 500,000 older Louisiana residents rely for health care, is facing calls for change in Congress.

In 2026, Medicare participants will pay more for their health care. Part B costs are expected to rise more than 10%. Here's ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...